Prevalence of inflammatory bowel disease in patients with pyoderma gangrenosum: A population-based analysis

J Am Acad Dermatol. 2022 Jun;86(6):1351-1352. doi: 10.1016/j.jaad.2021.05.006. Epub 2021 May 8.

Authors

Amy Xu¹, Andrew Strunk¹, Amit Garg¹, Allireza Alloo²

Affiliations

¹ Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York.
² Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York. Electronic address: aalloo@northwell.edu.

PMID: 33971254
DOI: 10.1016/j.jaad.2021.05.006

No abstract available

MeSH terms

Humans
Inflammatory Bowel Diseases* / complications
Inflammatory Bowel Diseases* / epidemiology
Infliximab
Prevalence
Pyoderma Gangrenosum* / epidemiology

Substances

Infliximab